Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score

Jianping Long, Xiaoke Chai, Tao Zhang, Chongyi Wei, Tao Yang, Haicun Zhou, Xiufen Ma · 2026

Read Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score by Jianping Long, Xiaoke Chai, Tao Zhang, Chongyi Wei, Tao Yang, Haicun Zhou, Xiufen Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13559661.txt.

Description

Long and colleagues published a 2026 study on a blood score that forecasts chemo success in breast cancer. The HALP score mixes blood counts and a nutrition protein into one number. It reflects immunity, nutrition, and inflammation in a single cheap index. The team studied 314 patients who had chemo before surgery.

After balancing the groups, 226 patients fed the main model checks. Low HALP scores halved the odds of full tumor clearance at surgery. A hormone-related tumor trait, HER2, raised clearance odds fivefold instead. Higher scores also tracked with longer survival without disease return. Their chart tool may help tailor treatment plans before chemo starts. Outside hospitals must still test the chart before wide use.

Catalog record

CREATORJianping Long, Xiaoke Chai, Tao Zhang, Chongyi Wei, Tao Yang, Haicun Zhou, Xiufen Ma
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13559661

Browse the full library · About the Tower of Babel